Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Description
Medicinal Parts
The drug consists of the dried bark of the trunk of Prunus africana.
Botanical Description
An evergreen tree, usually 10-25 m high, with straight, cylindrical trunk and dense, rounded crown. Leaves alternate, 8-12 cm long, long-stalked, simple, elliptic, bluntly pointed at apex, with shallow crenate margins; leathery, deep green, and glossy, with midrib sharply impressed or channelled on upper surface and strongly prominent on underside; smell of almonds when bruised. Leafstalks and young branchlets often reddish. Flowers small, white or cream, fragrant, in axillary racemes 3-8 cm long; corolla lobes up to 2 mm long. Fruits cherry-shaped, red to purplish-brown, 8-12 mm in diameter; very bitter flesh and bony stone. Wood pale red, with strong cyanide smell when freshly cut, darkening to rich dark red or mahogany-brown on exposure to air; straight-grained and even textured, strong and elastic, very hard and very heavy.
Habitat
The tree occurs in tropical and subtropical parts of Africa, including Angola, Cameroon, Ethiopia, Ghana, Kenya, Madagascar, Malawi, Mozambique, Republic of Congo, South Africa, Uganda, United Republic of Tanzania, Zambia and Zimbabwe, Burundi, Equatorial Guinea (Bioko, Sao Tome and Principe), Rwanda, Sudan, and Swaziland.
Production
Wild-crafted. Wild-harvesting of bark is very destructive and some attempts have been made to establish plantations for sustainable bark production. Fresh bark is harvested, dried, crushed, and extract obtained from which a drug is segregated. Bark harvesting occurs year-round.
Other Names
African plum tree, African prune tree, alumty, iluo, kirah, Natal tree, prunier d'afrique, vla, wotangue, armaatet, chati, inkhokhokho, inyangazoma-elimnyama, kiburabura, lemalan migambo, mueri, muiru, murugutu, mutimailu, mweria, mwiritsa, nuwehout, ol-koijuk, oromoti, red stinkwood, rooistinkhout, tenduet, tendwet, twendet, umdumizulu, umkakase, umkhakhazi, umlalume; mwiluti, mfila, mpembati, mdundulu, ligambo, mufubia, gwaami, kondekonde, olkonjuku, mkonde-konde.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Actions & Pharmacology
Compounds
Docosanol (0.6%) and β-sitosterol (15.7%). Other major constituents include alkanols: tetracosanol (0.5%) and trans-ferulic acid esters of docosanol and tetracosanol, fatty acids (62.3%, comprising myristic, palmitic, linoleic, oleic, stearic, arachidic, behenic and lignoceric acids); sterols: sitosterone (2.0%) and daucosterol and triterpenes: ursolic acid (2.9%), friedelin (1.4%), 2-a-hydroxyursolic acid (0.5%), epimaslinic acid (0.8%) and maslinic acid.
Effects
Multiple mechanisms have been proposed for the genitourinary effects of prunus, including 5α-reductase inhibition, estrogenic effects, and anti-inflammatory properties. Genitourinary effects: P. africana extract appears to inhibit human prostatic 5α-reductase (IC50 63,000 ng/mL), but much less powerfully than finasteride (IC50 1.0 ng/mL). Reduction of urethral obstruction and improvement of bladder function have been observed. Most studies of P. africana extract have addressed outcomes related to the obstructive component. In rats, prunus inhibits dihydrotestosterone-induced prostate hyperplasia, with a mechanism that appears unrelated to androgen receptor blockade. In rats and humans, P. africana extract has been found to stimulate secretory activity of the prostate and seminal vesicles. Reduction of contractile dysfunction of the bladder caused by partial outlet obstruction has been observed with pre-treatment of rabbits with P. africana extract (Tadenan®, 1-100mg/kg/day oral).
Anti-inflammatory effects
In vitro studies report P. africana extract to inhibit production of 5-lipoxygenase metabolites at concentrations of 3mcg/mL when dissolved in DMSO, and 10mcg/mL when dissolved in NaOH/HCl (p<0.01). P. africana inhibits fibroblast proliferation induced by epidermal growth factor (EGF; IC50=4.5mcg/mL), insulin-like growth factor type I (IGF-I; IC50=7.7mcg/mL), and basic fibroblast growth factor (bFGF; IC50=12.6mcg/mL) in vitro. P. africana extract appears to possess phytoestrogenic properties.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Clinical TrialsBenign prostatic hypertrophy/BPH symptoms
In 2002, Wilt et al conducted a systematic review and meta-analysis to investigate the evidence surrounding the use of prunus in the treatment of BPH. The authors searched for trials in multiple databases, including Medline, Embase, the Cochrane Library, Phytodok, by checking bibliographies, and by contacting relevant manufacturers and researchers. Trials were eligible if they were randomized, included men with BPH, compared preparations of Prunus africana (alone or in combination) with placebo or other BPH medications, and if they included clinical outcomes such as urologic symptom scales, symptoms, or urodynamic measurements. The main outcome measure for adverse effects was the number of men reporting adverse effects. A total of 18 randomized controlled trials involving 1562 men met inclusion criteria and were analyzed. Only one of the studies reported a method of treatment allocation concealment, although 17 were double-blinded. There were no studies comparing Prunus africana to standard pharmacologic interventions such as alpha-adrenergic blockers or 5-alpha reductase inhibitors. The mean study duration was 64 days (range, 30-122 days). According to the authors, most studies did not report results in a method that permitted meta-analysis. Compared to men receiving placebo, prunus provided a moderately large improvement in the combined outcome of urologic symptoms and flow measures as assessed by an effect size defined by the difference of the mean change for each outcome divided by the pooled standard deviation for each outcome (-0.8 SD [95% confidence interval (CI), -1.4, -0.3 (n=6 studies)]). Men using prunus were more than twice as likely to report an improvement in overall symptoms (RR=2.1, 95% CI = 1.4, 3.1). Nocturia was reduced by 19%, residual urine volume by 24%, and peak urine flow was increased by 23%. Adverse effects due to prunus were mild and comparable to placebo.
The overall dropout rate was 12% and was similar between prunus (13%), placebo (11%) and other controls (8%). Although the authors concluded that standardized preparations of prunus may be a useful treatment option for men with lower urinary symptoms consistent with BPH, they noted that further research is necessary, as the reviewed studies overall were small in size, short in duration, used varied doses/preparations, and rarely reported outcomes using standardized validated measures of efficacy (Wilt et al, 2002).
In 2000, Ishani et al. conducted a systematic review and meta-analysis of 18 randomized controlled trials to evaluate the efficacy of prunus extract in the treatment of symptomatic BPH. Out of 31 randomized trials with a duration of 30 days or greater, 18 matched the inclusion criteria for this analysis. All 18 trials were conducted in Europe and included a total of 1562 subjects. Ten trials compared P. africana to placebo, two trials evaluated P. africana versus an anti-inflammatory drug, one study compared P. africana to both placebo and P. africana plus medroxyprogesterone, one trial compared once daily versus twice daily dosing of P. africana, two trials compared P. africana combined with another herbal vs. placebo, one trial compared P. africana to another herbal agent, and one trial compared two different doses of P. africana plus Urtica dioica. The doses of P. africana extract used in trials varied from 75mg to 200mg per day. The data were pooled using two methods: First, for summarizing trials with various outcome measures, treatment effect size for continuous variables was assessed by dividing the difference of the mean change for each outcome by the pooled standard deviation for that outcome. Second, effect size was estimated using the most clinically important outcome per study, according to the following preference scale: symptom score > nocturia > peak urine flow > residual urine volume. The summary effect size (difference in mean outcome divided by the pooled standard deviation for that outcome) was then assessed using the following key: 0.8 = large effect, 0.5 = moderate effect, 0.2 = small effect. Among 474 men from six trials comparing P. africana to placebo, summary effect size was calculated to be -0.8 (95%CI -1.4 to -0.3), which suggests a large, statistically significant improvement in symptomatic BPH with P. africana compared to placebo.
Furthermore, men taking P. africana were 2.1 (95%CI 1.4 to 3.4) times more likely experience an overall improvement of symptoms than those taking placebo, and also experienced a 19% reduction in nocturia as compared with those taking placebo (weighted mean difference of -0.9). The latter two results, however, were not statistically significant (95%CI -2.0 to 0.1). Peak urine flow, as analyzed from four trials (363 subjects), was significantly increased by 23% as compared to placebo (95% CI 0.3 to 4.7). For none of the effect measures, in none of the analyzed studies, was control treatment superior to P. africana extract (Ishani et al, 2000).
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Indications & UsageUnproven Uses
Aphrodisiac, bladder sphincter disorders, fever, impotence, inflammation, kidney disease, malaria, male baldness, partial bladder outlet obstruction, prostate cancer, prostatic adenoma, prostatitis, psychosis, sexual performance, stomach upset, urinary tract health. Prunus africana is traditional medicine in Africa used to treat chest pain, malaria, and fevers (Cunningham and Mbenkum 1993). The fresh bark, leaf, and fruits contain amygalin, yielding hydrocyanic acid when crushed; hence, they have an almond flavor. The bark was traditionally powdered and drunk as tea for genitourinary complaints, allergies, inflammation, kidney disease, malaria, stomach ache, and fever, among other uses.
Possible Efficacy
Treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH) stages I and II, as defined by Aiken (e.g. nocturia, polyuria and urinary retention), where diagnosis of prostate cancer is negative.
Pediatrics
There is not sufficient scientific information to recommend prunus for use in children.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
ContraindicationsPregnancy/lactation
Prunus cannot be recommended during pregnancy or breast-feeding because of a lack of scientific information and possible hormonal effects.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Precautions & Adverse Reactions
Caution in taking 5 α-reductase inhibitors or saw palmetto
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Drug InteractionsPotential Interactions
Prunus extract appears to inhibit human prostatic 5α-reductase. In theory, prostate specific antigen (PSA) values in serum may be reduced with the use of 5α-reductase inhibitors, masking otherwise elevated levels. Prunus may interact with estrogen or other hormones. Prunus may interact with herbs/supplements containing chemicals with estrogen-like constituents.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
DosageHow Supplied
Lipophilic extract of the crude drug.
Daily Dose
75-200mg lipidosterolic extract of the crude drug, in divided doses. To minimize gastrointestinal disturbances, take with food or milk.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.
LiteratureAndro M, Riffaud J. Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia: a review of 25 years of published experience. Curr Ther Res 1995;56(8):796-817.Anon. [Tadenan (Pygeum africanum extract) in the treatment of patients with benign prostatic hyperplasia]. Urologia 2004 Sep-Oct;(5):70-2.Anon. Pygeum africanum (Prunus africanus) (African plum tree). Monograph. Altern Med Rev 2002 Feb;7(1):71-4.Barry M. Review: Pygeum africanum extracts improve symptoms and urodynamics in symptomatic benign prostatic hyperplasia. ACP J Club 2002 Sep-Oct;137(2):61.Bombardelli E, Morazzoni P. Prunus africana (Hook. f) Kalkm. Fitoterapia, 1997, 68: 205-218.Buck AC. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action. J Urol 2004 Nov;172(5 Pt 1):1792-9.Chen MW, Levin RM, Horan P, Buttyan RB. Effects of Unilateral Ischemia on theContractile Response of the Bladder: Protective Effect of Tadenan (Pygeum africanum Extract). Mol Urol, 1999, 3(1):5-10.Choo MS, Bellamy F, Constantinou CE. Functional evaluation of Tadenan on micturition and experimental prostate growth induced with exogenous dihydrotestosterone. Urology 2000 Feb;55(2):292-8.Cristoni A, Di Pierro F, Bombardelli E. Botanical derivatives for the prostate. Fitoterapia, 2000, 71 Suppl 1:S21-8.Dreikorn K. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia. World J Urol 2002 Apr;19(6):426-35.Dreikorn K. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia. Curr Urol Rep 2000 Aug;1(2):103-9.Dreikorn K, Berges R, Pientka L, Jonas U. [Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation]. Urologe A 2002 Sep;41(5):447-51.Dutkiewicz S. Usefulness of Cernilton in the treatment of benign prostatic hyperplasia. Int Urol Nephrol 1996;28(1):49-53.Gathumbi PK, Mwangi JW, Mugera GM, Njiro SM. Toxicity of chloroform extract of prunus africana stem bark in rats: gross and histological lesions. Phytother Res, 2002 May;16(3):244-7.Gathumbi PK, Mwangi JW, Njiro SM, Mugera GM. Biochemical and haematological changes in rats administered an aqueous extract of Prunus africana stem-bark at various dosage levels. Onderstepoort J Vet Res 2000 Jun;67(2):123-8.Gerber GS. Phytotherapy for benign prostatic hyperplasia. Curr Urol Rep 2002 Aug;3(4):285-91.Hartmann RW, Mark M, Soldati F. Inhibition of 5a-reductase and aromatase by PHL00801 (Prostatonin®), a combination of PY 102 (Pygeum africanum) and DR 102 (Urtica dioica) extracts. Phytomedicine, 1996,3:121-128.Hass MA, Nowak DM, Leonova E, Levin RM, Longhurst PA. Identification of components of Prunus africana extract that inhibit lipid peroxidation. Phytomedicine, 1999 Nov;6(5):379-88.Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am J Med 2000 Dec 1;109(8):654-64.Levin RM, Das AK. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urol Res 2000 Jun;28(3):201-9.Lowe FC, Ku J. Phytotherapy in the treatment of benign prostatic hyperplasia: a critical review. Urology 1996, 48:12-20.Mathe G, Hallard M, Bourut CH, Chenu E. A Pygeum africanum extract with so-called phyto-estrogenic action markedly reduces the volume of true and large prostatic hypertrophy. Biomed Pharmacother 1995;49(7-8):341-3.Mathe G, Orbach-Arbouys S, Bizi E, Court B. The so-called phyto-estrogenic action of Pygeum africanum extract. Biomed Pharmacother 1995;49(7-8):339-40.McQueen CE, Bryant PJ. Pygeum. Am J Health Syst Pharm 2001;58(2):120-123.Nieri E et al. New lignans from Prunus africana Hook. Rivista ltaliana Eppos, 1996, 7: 27-31.Santa Maria Margalef A, Paciucci Barzanti R, Reventos Puigjaner J, Morote Robles J,Thomson Okatsu TM. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia]. Arch Esp Urol 2003 May;56(4):369-78.Stewart KM. The African cherry (Prunus africana): can lessons be learned from an over-exploited medicinal tree? J Ethnopharmacol 2003 Nov;89(1):3-13.Strong KM. African plum and benign prostatic hypertrophy. J Herb Pharmcother 2004;4(1):41-6.Szolnoki E, Reichart E, Marchal S, Szegedi G. The effect of Pygeum africanum on fibroblast growth factor (FGF) and transforming growth factor beta (TGF beta 1/LAP) expression in animal model. Acta Microbiol Immunol Hung 2001;48(1):1-9.Verschaeve L, Kestens V, Taylor JL, Elgorashi EE, Maes A, Van Puyvelde L, De Kimpe N,Van Staden J. Investigation of the antimutagenic effects of selected South African medicinal plant extracts. Toxicol In Vitro 2004 Feb;18(1):29-35.Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev 2002;(1):CD001044.Yablonsky F, Nicolas V, Riffaud JP, Bellamy F. Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts. J Urol 1997 Jun;157(6):2381-7.Yarnell E. Botanical medicines for the urinary tract. World J Urol 2002 Nov;20(5):285-93. Epub 2002 Oct 17.Pure Matters Saw Palmetto with Pygeum naturally supports overall urinary health.













